Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Pluristem Therapeutics Inc. (PSTI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.2900+0.0300 (+2.38%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close1.2600
Open1.2600
Bid1.2300 x 800
Ask1.2900 x 1400
Day's Range1.2400 - 1.3100
52 Week Range1.0600 - 3.9300
Volume55,972
Avg. Volume106,996
Market Cap41.728M
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-1.4620
Earnings DateFeb 16, 2019 - Feb 19, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.17
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PSTI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pluristem Therapeutics, Inc.
    VCEL: What does Argus have to say about VCEL?VERICEL CORP has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Insider Monkey

    10 Best Biotech Penny Stocks To Buy Now

    In this article, we discuss the 10 best biotech penny stocks to buy now. If you want to skip our detailed analysis of the biotech sector, go directly to 5 Best Biotech Penny Stocks To Buy Now. Like all sectors of the economy right now, the biotech sector is going through a lot of pain. The […]

  • Insider Monkey

    10 Biotech Penny Stocks with Growth Catalysts

    In this article, we discuss 10 biotech penny stocks with growth catalysts. If you want to see some more stocks in this selection, check out 5 Biotech Penny Stocks with Growth Catalysts. According to Global Market Insights, the market for biotech in 2020 was valued at $497 billion, and it is forecasted to grow to […]

  • GlobeNewswire

    Pluristem and Tnuva to Ring Nasdaq Closing Bell in Honor of New Partnership

    Closing Bell Ringing Ceremony Will Take Place on Monday, March 28 at 3:45 pm ET at Nasdaq MarketSite in Times Square, New York A live stream of the Nasdaq Closing Bell will be available at: https://livestream.com/accounts/27896496/events/10177910 HAIFA, Israel, March 28, 2022 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI) (“Pluristem”), a leading biotechnology company, and Tnuva Group (“Tnuva Group” or “Tnuva”), Israel’s largest food producer, today announced that Pl

Advertisement
Advertisement